Softbank Vision FUND (aiv M1) L.P., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 113,986 shares at $27.21 ($3.1M) on 2022-11-25, disclosed to the SEC on 2022-11-28.
Open-market sale of $3.1M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.30 | 39,729 | $1.1M | 34.9% |
| 2 | $27.30 | 39,729 | $1.1M | 34.9% |
| 3 | $27.21 | 17,264 | $470K | 15.1% |
| 4 | $27.21 | 17,264 | $470K | 15.1% |
| Total | $27.27 avg | 113,986 | $3.1M | 100% |
| Filing → |
| VIR | SELL | 2023-07-05 | $18K | — | Filing → |
| COMP | SELL | 2023-06-09 | $55.4M | — | Filing → |
| VIR | SELL | 2023-04-18 | $1.0M | — | Filing → |